| Inherited determinants of early recurrent somatic mutations in prostate cancer A Romanel, S Garritano, B Stringa, M Blattner, D Dalfovo, D Chakravarty, ... Nature communications 8 (1), 48, 2017 | 33 | 2017 |
| LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice R Prakasam, A Bonadiman, R Andreotti, E Zuccaro, D Dalfovo, ... Nature Communications 14 (1), 603, 2023 | 10 | 2023 |
| Analysis of genetic ancestry from NGS data using EthSEQ D Dalfovo, A Romanel Current Protocols 3 (2), e663, 2023 | 3 | 2023 |
| Polympact: exploring functional relations among common human genetic variants S Valentini, F Gandolfi, M Carolo, D Dalfovo, L Pozza, A Romanel Nucleic Acids Research 50 (3), 1335-1350, 2022 | 3 | 2022 |
| Exploring functionally annotated transcriptional consensus regulatory elements with CONREL D Dalfovo, S Valentini, A Romanel Database 2020, baaa071, 2020 | 3 | 2020 |
| Germline determinants of aberrant signaling pathways in cancer D Dalfovo, R Scandino, M Paoli, S Valentini, A Romanel npj Precision Oncology 8 (1), 57, 2024 | | 2024 |
| Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across … WC Lim, ME Marques Da Costa, K Godefroy, E Jacquet, L Gragert, ... Frontiers in immunology 14, 1265469, 2024 | | 2024 |
| Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer D De Felice, A Alaimo, D Bressan, S Genovesi, E Marmocchi, N Annesi, ... biorxiv, 2024.03. 06.583256, 2024 | | 2024 |
| Abstract LB-232: Inherited determinants of early recurrent somatic mutations in prostate cancer A Romanel, SI Garritano, B Stringa, M Blattner, D Dalfovo, D Chakravarty, ... Cancer Research 77 (13_Supplement), LB-232-LB-232, 2017 | | 2017 |
